BackgroundFunctional data is data represented by functions (curves or surfaces of a low-dimensional index). Functional data often arise when measurements are collected over time or across locations. In the field of medicine, plasma lipoprotein particles can be quantified according to particle diameter by ion mobility.GoalWe wanted to evaluate the utility of functional analysis for assessing the association of plasma lipoprotein size distribution with cardiovascular disease after adjustment for established risk factors including standard lipids.MethodsWe developed a model to predict risk of cardiovascular disease among participants in a case-cohort study of the Malmö Prevention Project. We used a linear model with 311 coefficients, correspon...
Background Alterations in plasma lipoprotein subclass distribution affect the risk for coronary arte...
BACKGROUND: Cardiovascular disease risk increases when lipoprotein metabolism is dysfunctional. We h...
Background: Cardiovascular disease risk increases when lipoprotein metabolism is dysfunctional. We h...
BackgroundFunctional data is data represented by functions (curves or surfaces of a low-dimensional ...
Background Functional data is data represented by functions (curves or surfaces of a low-dimensional...
Background and aims After assessing the risk for cardiovascular disease (CVD) based on traditional r...
BACKGROUND: Low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol...
Increased plasma cholesterol is a known risk factor for cardiovascular disease. Lipoprotein particle...
A predominance of small, dense low-density lipoproteins (LDL) has been accepted as an emerging cardi...
The development of trends and practice-oriented approaches to personalized programs for the diagnosi...
OBJECTIVE: Whereas epidemiological studies show that levels of low-density lipoprotein cholesterol (...
There are numerous particles, enzymes, and mechanisms in the lipid metabolism that are involved in t...
Background: Dyslipidemia is a hallmark of cardiovascular disease but is characterized by crude measu...
A predominance of small, dense low-density lipoproteins (LDL) has been accepted as an emerging cardi...
BACKGROUND: Plasma lipidomic measures may enable improved prediction of cardiovascular outcomes in s...
Background Alterations in plasma lipoprotein subclass distribution affect the risk for coronary arte...
BACKGROUND: Cardiovascular disease risk increases when lipoprotein metabolism is dysfunctional. We h...
Background: Cardiovascular disease risk increases when lipoprotein metabolism is dysfunctional. We h...
BackgroundFunctional data is data represented by functions (curves or surfaces of a low-dimensional ...
Background Functional data is data represented by functions (curves or surfaces of a low-dimensional...
Background and aims After assessing the risk for cardiovascular disease (CVD) based on traditional r...
BACKGROUND: Low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol...
Increased plasma cholesterol is a known risk factor for cardiovascular disease. Lipoprotein particle...
A predominance of small, dense low-density lipoproteins (LDL) has been accepted as an emerging cardi...
The development of trends and practice-oriented approaches to personalized programs for the diagnosi...
OBJECTIVE: Whereas epidemiological studies show that levels of low-density lipoprotein cholesterol (...
There are numerous particles, enzymes, and mechanisms in the lipid metabolism that are involved in t...
Background: Dyslipidemia is a hallmark of cardiovascular disease but is characterized by crude measu...
A predominance of small, dense low-density lipoproteins (LDL) has been accepted as an emerging cardi...
BACKGROUND: Plasma lipidomic measures may enable improved prediction of cardiovascular outcomes in s...
Background Alterations in plasma lipoprotein subclass distribution affect the risk for coronary arte...
BACKGROUND: Cardiovascular disease risk increases when lipoprotein metabolism is dysfunctional. We h...
Background: Cardiovascular disease risk increases when lipoprotein metabolism is dysfunctional. We h...